Human epidermal growth factor receptor 2 (HER2) is a tyrosine kinase receptor with a molecular weight of 185 kDa, which is overexpressed in breast cancer, gastric cancer, ovarian cancer, lung cancer and liver cancer (19–23). This evidence concerns the gene ERBB2 and breast carcinoma.